Reliance seeks nod to use tapeworm drug for covid-19 treatment
Tapeworm drug Niclosamide, which is on the WHO's list of essential medicines for treating covid-19 cases, is also on a phase 2 trial of 96 subjects by Telangana-based Laxai Life Sciences Pvt. Ltd